This inventor holds 2 USPTO granted patents. Top assignees: Biochem Pharma Inc., Zambon Group. Active years: 1997-2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997-2001
Title: The Innovative Contributions of Jean-Louis Kraus
Introduction
Jean-Louis Kraus is a notable inventor based in Marseilles, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with antiviral and anticancer properties. With a total of two patents to his name, Kraus has demonstrated a commitment to advancing medical science through his innovative work.
Latest Patents
Kraus's latest patents include the development of pyrimidinone-1,3-oxathiolane derivatives with antiviral activity. These compounds are characterized by formula (I), wherein R and R can be hydrogen atoms, acyl groups derived from lower carboxylic acids, or chains of formula (a). They are particularly useful as reverse transcriptase inhibitors. Additionally, he has worked on heterocyclic anthracycline analogs, which are novel pyrano heterocyclic anthracycline derivatives. These compounds are beneficial in treating various cancers, including breast cancer, leukemia, lung cancer, colon cancer, ovarian cancer, renal cancer, and melanoma. Furthermore, these compounds can be utilized ex vivo for treating cancerous bone marrow before retransplanting it into patients. His patents also describe pharmaceutical compositions and methods for preparing these compounds.
Career Highlights
Throughout his career, Kraus has been associated with prominent companies in the pharmaceutical industry, including Biochem Pharma Inc. and Zambon Group S.p.a. His work has significantly impacted the development of new therapeutic agents, showcasing his expertise and dedication to improving patient outcomes.
Collaborations
Kraus has collaborated with notable professionals in his field, including Giorgio Attardo and Marc Courchesne. These partnerships have likely contributed to the success of his innovative projects and patents.
Conclusion
Jean-Louis Kraus is a distinguished inventor whose work in pharmaceuticals has led to the development of important antiviral and anticancer compounds. His contributions continue to influence the medical field, highlighting the importance of innovation in addressing health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile